The continuous measurement of anti-CCP-antibodies does not help to evaluate the disease activity in anti-CCP-antibody-positive patients with rheumatoid arthritis

Clinical Rheumatology

Volumn 29, Issue 12, 2010, Pages 1449-1453

  Landmann, Thoren ^a,b   Kehl, Gabriele ^b   Bergner, Raoul ^b  

^a Kuratorium für Dialyse und Nierentransplantation e V KfH Kidney Center   (Germany)

^b KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Anti CCP antibodies; Disease activity; Follow up; Rheumatoid arthritis

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; RITUXIMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; AGED; ARTICLE; DISEASE ACTIVITY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MORNING STIFFNESS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; ARTHRITIS, RHEUMATOID; HUMANS; MIDDLE AGED; PEPTIDES, CYCLIC; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 78649331283     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-010-1557-5     Document Type: Article

References (17)

1. JP Riedemann S Munoz A Kavanaugh 2005 The use of second generation anti-CCP-antibody antibody (anti-CCP-antibody2) testing in rheumatoid arthritis-a systematic review Clin Exp Rheumatol 23 69 76
2. J Avouac L Gossec M Dougados 2006 Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review Ann Rheum Dis 65 845 851 1:CAS:528: DC%2BD28XntF2mu7Y%3D 10.1136/ard.2006.051391 16606649
3. DA Del Val BR Ibanez MC Fito PR Gutierrez CE Loza 2006 Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness Clin Exp Rheumatol 24 281 286
4. L Tant S Steinfeld 2006 Anti-CCP antibody test: diagnostic and pronostic values in rheumatoid arthritis Rev Méd Brux 27 95 98 1:STN:280: DC%2BD28zhs1Wjtw%3D%3D 16736847
5. S Agrawal R Misra A Aggarwal 2007 Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA Clin Rheumatol 26 201 204 10.1007/s10067-006-0275-5 16572283 (Pubitemid 46020244)
6. K Nishimura D Sugiyama Y Kogata G Tsuji T Nakazawa S Kawano K Saigo A Morinobu M Koshiba KM Kuntz I Kamae S Kumagai 2007 Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis Ann Intern Med 146 797 808 17548411
7. E Berglin T Johansson U Sundin E Jidell G Wadell G Hallmans S Rantapaa-Dahlqvist 2006 Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset Ann Rheum Dis 65 453 458 1:STN:280:DC%2BD287ktFKjsA%3D%3D 10.1136/ard.2005.041376 16176994
8. HA Chen KC Lin CH Chen HT Liao HP Wang HN Chang CY Tsai CT Chou 2006 The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis Ann Rheum Dis 65 35 39 1:CAS:528:DC%2BD28Xnt12htA%3D%3D 10.1136/ard.2005.038851 15975966 (Pubitemid 41815636)
9. S Sihvonen M Korpela A Mustila J Mustonen 2005 The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis J Rheumatol 32 2089 2094 1:CAS:528:DC%2BD2MXht12ltbrJ 16265684
10. S Aotsuka M Okawa-Takatsuji K Nagatani C Nagashio T Kano K Nakajima K Ito A Mimori 2005 A retrospective study of the fluctuation in serum levels of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis Clin Exp Rheumatol 23 475 481 1:STN:280:DC%2BD2MvivFSiug%3D%3D 16095115
11. I Alexiou A Germenis A Ziogas K Theodoridou LI Sakkas 2007 Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis BMC Musculoskelet Disord 8 37 10.1186/1471-2474-8-37 17448247 (Pubitemid 46788700)
12. AM Abdel-Nasser MH Mahmoud TM El Mansoury AM Osman 2008 Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis Scand J Rheumatol 37 329 336 1:CAS:528:DC%2BD1cXhtFOrtb7F 10.1080/03009740802116208 18666028
13. N Inanc E Dalkilic S Kamali E Kasapoglu-Gunal Y Elbir H Direskeneli M Inanc 2007 Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis Clin Rheumatol 26 17 23 1:STN:280:DC%2BD2s%2FoslGlug%3D%3D 10.1007/s10067-006- 0214-5 16538391 (Pubitemid 46020016)
14. B Onder A Kurtaran S Kimyon B Selcuk M Akyuz 2009 Association of anti-CCP positivity with serum ferritin and DAS-28 Rheumatol Int 30 223 227 10.1007/s00296-009-0941-4
15. C Alessandri M Bombardieri N Papa M Cinquini L Magrini A Tincani G Valesini 2004 Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement Ann Rheum Dis 63 1218 1221 1:CAS:528:DC%2BD2cXovFOmsrg%3D 10.1136/ard.2003.014647 15361374 (Pubitemid 39273496)
16. C Potter KL Hyrich A Tracey M Lunt D Plant DMP Symmons W Thomson J Worthington P Emery AW Morgan AG Wilson J Isaacs A Barto BRAGGSS 2009 Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis Ann Rheum Dis 68 69 74 1:CAS:528:DC%2BD1MXhslOlt70%3D 10.1136/ard.2007.084715 18375541
17. A Kastbom G Strandberg A Lindroos T Skogh 2004 Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project) Ann Rheum Dis 63 1085 1089 1:CAS:528:DC%2BD2cXnvFWkt7s%3D 10.1136/ard.2003.016808 15308517 (Pubitemid 39120359)